These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12456053)

  • 1. Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease.
    Arendt T
    J Neural Transm Suppl; 2002; (62):77-85. PubMed ID: 12456053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain.
    Arendt T
    Neurobiol Aging; 2000; 21(6):783-96. PubMed ID: 11124422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease.
    Arendt T
    Int J Dev Neurosci; 2001 Jun; 19(3):231-45. PubMed ID: 11337192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization.
    Arendt T
    Neuroscience; 2001; 102(4):723-65. PubMed ID: 11182240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease as a disorder of dynamic brain self-organization.
    Arendt T
    Prog Brain Res; 2005; 147():355-78. PubMed ID: 15581717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
    Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
    Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity.
    Arendt T
    Prog Neurobiol; 2003 Oct; 71(2-3):83-248. PubMed ID: 14687983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.
    Bondareff W; Mountjoy CQ; Roth M; Hauser DL
    Neurobiol Aging; 1989; 10(6):709-15. PubMed ID: 2628782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.
    Copani A; Guccione S; Giurato L; Caraci F; Calafiore M; Sortino MA; Nicoletti F
    Curr Med Chem; 2008; 15(24):2420-32. PubMed ID: 18855671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain.
    Arendt T; Brückner MK; Gertz HJ; Marcova L
    Neuroscience; 1998 Apr; 83(4):991-1002. PubMed ID: 9502241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death.
    Arendt T; Holzer M; Stöbe A; Gärtner U; Lüth HJ; Brückner MK; Ueberham U
    Ann N Y Acad Sci; 2000; 920():249-55. PubMed ID: 11193159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease.
    Herrup K; Arendt T
    J Alzheimers Dis; 2002 Jun; 4(3):243-7. PubMed ID: 12226544
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell cycle activation and aneuploid neurons in Alzheimer's disease.
    Arendt T
    Mol Neurobiol; 2012 Aug; 46(1):125-35. PubMed ID: 22528601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity.
    Arendt T; Brückner MK
    Biochim Biophys Acta; 2007 Apr; 1772(4):413-21. PubMed ID: 17236750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease.
    Vincent I; Bu B; Hudson K; Husseman J; Nochlin D; Jin L
    Neuroscience; 2001; 105(3):639-50. PubMed ID: 11516829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease.
    Zilkova M; Koson P; Zilka N
    Bratisl Lek Listy; 2006; 107(9-10):366-73. PubMed ID: 17262989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.